ASX:CLVClover Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Clover Co. Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$2.13 -0.06 (-2.74 %) (As of 05/13/2020) Add Compare Share Today's RangeA$2.07Now: A$2.13▼A$2.1850-Day RangeA$2.13MA: A$2.13▼A$2.1352-Week RangeA$1.33Now: A$2.13▼A$3.31Volume210,197 shsAverage Volume127,440 shsMarket Capitalization$354.24 millionP/E Ratio34.92Dividend Yield1.08%BetaN/A ProfileAdvanced ChartCompetitorsDividendEarningsInsider TradesHeadlines Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. The company is also involved in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milk products, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. The company was founded in 1988 and is headquartered in Altona North, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Clover. Previous Next 3.0 Community Rank Outperform VotesClover has received 63 “outperform” votes. (Add your “outperform” vote.)Underperform VotesClover has received 43 “underperform” votes. (Add your “underperform” vote.)Community SentimentClover has received 59.43% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Clover and other stocks. Vote “Outperform” if you believe CLV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.8 Dividend Strength Dividend YieldClover has a dividend yield of 1.08%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthClover does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Clover is 32.79%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clover insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Clover are expected to decrease by -100.00% in the coming year, from A$0.04 to A$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover is 34.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.73.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover is 34.92, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 25.04.Price to Book Value per Share RatioClover has a P/B Ratio of 7.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.77 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolASX:CLV Previous Symbol CUSIPN/A CIKN/A Webwww.clovercorp.com.au Phone+61-3-83475000Debt Debt-to-Equity Ratio32.26 Current Ratio4.92 Quick Ratio1.32Price-To-Earnings Trailing P/E Ratio34.92 Forward P/E Ratio55.00 P/E GrowthN/A Sales & Book Value Annual Sales$80.04 million Price / Sales4.43 Cash FlowA$0.00 per share Price / Cash Flow-2,130.00 Book ValueA$0.30 per share Price / Book7.17Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees39 Outstanding Shares166,310,000Market Cap$354.24 million Next Earnings DateN/A OptionableNot Optionable Receive CLV News and Ratings via Email Sign-up to receive the latest news and ratings for CLV and its competitors with MarketBeat's FREE daily newsletter. Clover (ASX:CLV) Frequently Asked Questions How has Clover's stock been impacted by COVID-19 (Coronavirus)? Clover's stock was trading at A$2.28 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLV shares have decreased by 6.6% and is now trading at A$2.13. View which stocks have been most impacted by Coronavirus. How were Clover's earnings last quarter? Clover Co. Limited (ASX:CLV) released its quarterly earnings results on Wednesday, March, 21st. The company reported $0.02 EPS for the quarter. View Clover's earnings history. How often does Clover pay dividends? What is the dividend yield for Clover? Clover announced a Final dividend on Monday, September 23rd. Shareholders of record on Wednesday, November 20th will be paid a dividend of 0.018 per share on Wednesday, November 20th. This represents a dividend yield of 0.64%. The ex-dividend date of this dividend is Tuesday, October 29th. View Clover's dividend history. Has Clover been receiving favorable news coverage? Press coverage about CLV stock has trended neutral this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Clover earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Clover. Who are some of Clover's key competitors? Some companies that are related to Clover include Advanced Medical Solutions Group (AMS), InfuSystem (INFU), Bovie Medical (BVX), CRH Medical (CRH), Tristel (TSTL), Retractable Technologies (RVP), CRH Medical (CRHM), CRH Medical (CRHM), SDI (SDI), Milestone Scientific (MLSS), Omega Diagnostics Group (ODX), Daxor (DXR), Daxor (DXR), IsoRay (ISR) and IsoRay (ISR). View all competitors. What other stocks do shareholders of Clover own? Based on aggregate information from My MarketBeat watchlists, some companies that other Clover investors own include South32 (S32), ServiceNow (NOW), Broadcom (AVGO), American Express (AXP), salesforce.com (CRM), Cisco Systems (CSCO), Dropbox (DBX), Enterprise Products Partners (EPD), Intel (INTC) and Micron Technology (MU). Who are Clover's key executives? Clover's management team includes the following people: Mr. Peter J. Davey MBA, gradDip Bus., GAICD, CEO, MD & Exec. DirectorMr. Paul A. Sherman C.A., M.B.A., B.Bus, CA, MBA, CFO & Company Sec.Mr. David Pierotti, Operations Mang.Dr. C. Patch, Chief Innovation OfficerS. Poothong, Chief Commercial Officer What is Clover's stock symbol? Clover trades on the ASX under the ticker symbol "CLV." What is Clover's stock price today? One share of CLV stock can currently be purchased for approximately A$2.13. How big of a company is Clover? Clover has a market capitalization of $354.24 million and generates $80.04 million in revenue each year. Clover employs 39 workers across the globe. What is Clover's official website? The official website for Clover is www.clovercorp.com.au. How can I contact Clover? Clover's mailing address is U 35E 1 International Dr, MELBOURNE, VIC 3049, Australia. The company can be reached via phone at +61-3-83475000. This page was last updated on 7/11/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
